Literature DB >> 15031188

Long term efficacy and safety of botulinum toxin A injection for crocodile tears syndrome.

D E Barañano, N R Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15031188      PMCID： PMC1772064          DOI： 10.1136/bjo.2003.029181

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report.

Authors:  R Riemann; S Pfennigsdorf; E Riemann; M Naumann
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

Review 2.  Evidence-based medicine: botulinum toxin in focal hyperhidrosis.

Authors:  M Naumann
Journal:  J Neurol       Date:  2001-04       Impact factor: 4.849

3.  Botulinum toxin A for the treatment of crocodile tears.

Authors:  Reha Yavuzer; Yavuz Başterzi; Fikret Akata
Journal:  Plast Reconstr Surg       Date:  2002-07       Impact factor: 4.730

4.  Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation.

Authors:  David J Keegan; Gerd Geerling; John P Lee; Glen Blake; J Richard Collin; Gordon T Plant
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

5.  Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland.

Authors:  F J Montoya; C E Riddell; R Caesar; S Hague
Journal:  Eye (Lond)       Date:  2002-11       Impact factor: 3.775

6.  Treatment of Frey's syndrome (gustatory sweating) and 'crocodile tears' (gustatory epiphora) with purified botulinum toxin.

Authors:  R J Hofmann
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-07       Impact factor: 1.746

7.  Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.

Authors:  B Boroojerdi; A Ferbert; M Schwarz; H Herath; J Noth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154
  7 in total
  8 in total

1.  [Botulinum toxin for the treatment of secretory disorders of the head and neck area].

Authors:  A Steffen
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

3.  Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.

Authors:  P Kaynak; G O Karabulut; C Ozturker; K Fazil; Y O Arat; I Perente; S Akar; O F Yilmaz; A Demirok
Journal:  Eye (Lond)       Date:  2016-05-20       Impact factor: 3.775

4.  Intraglandular injection of botulinum toxin a reduces tear production in rabbits.

Authors:  Anna M Demetriades; Ilya M Leyngold; Sam D'Anna; Allen O Eghrari; Dave G Emmert; Michael P Grant; Shannath L Merbs
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Jan-Feb       Impact factor: 1.746

Review 5.  [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].

Authors:  B Wabbels; M Förl
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.174

Review 6.  Use of Botulinum Neurotoxin in Ophthalmology.

Authors:  Emel Başar; Ceyhun Arıcı
Journal:  Turk J Ophthalmol       Date:  2016-12-01

7.  Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.

Authors:  Andrew G Lee; Shin-Hyo Lee; Minsu Jang; Sang Jae Lee; Hyun Jin Shin
Journal:  Toxins (Basel)       Date:  2021-01-21       Impact factor: 4.546

8.  Injection of Botulinum Toxin A in the Lacrimal Gland for Treatment of Epiphora in Crocodile Tears Syndrome - A Case Report.

Authors:  Mário Lima-Fontes; Mariana Leuzinger-Dias; Fernando Falcão-Reis; Cristina Sousa
Journal:  Int Med Case Rep J       Date:  2022-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.